Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging

Autor: Rebecca D. Dodd, Marion Vanneste, Michael B. Cohen, Patrick Breheny, Wade R. Gutierrez, James A. Brown, Michael D. Henry, Devon L. Moose, Nadine Bannick, Courtney Yong, Robert U. Svensson
Rok vydání: 2020
Předmět:
0301 basic medicine
Male
Carcinogenesis
animal diseases
Vimentin
Optical Analysis
medicine.disease_cause
Biochemistry
Metastasis
Prostate cancer
Mice
0302 clinical medicine
Basic Cancer Research
Medicine and Health Sciences
Medicine
Sequence Deletion
Mice
Knockout

Multidisciplinary
biology
Prostate Cancer
Genetically Modified Organisms
Prostate Diseases
Animal Models
Prostatic Neoplasms
Castration-Resistant

Lymphatic system
Oncology
Experimental Organism Systems
030220 oncology & carcinogenesis
Engineering and Technology
Anatomy
Genetic Engineering
Research Article
Biotechnology
Epithelial-Mesenchymal Transition
Imaging Techniques
Science
Urology
Mouse Models
Bioengineering
Research and Analysis Methods
03 medical and health sciences
Model Organisms
Exocrine Glands
Biomarkers
Tumor

PTEN
Animals
Epithelial–mesenchymal transition
Chemical Characterization
Monitoring
Physiologic

Genetically Modified Animals
business.industry
Bioluminescence Imaging
PTEN Phosphohydrolase
Cancers and Neoplasms
Biology and Life Sciences
Proteins
medicine.disease
Androgen receptor
Mice
Inbred C57BL

Disease Models
Animal

Genitourinary Tract Tumors
Cytoskeletal Proteins
030104 developmental biology
Luminescent Measurements
biology.protein
Cancer research
Animal Studies
Prostate Gland
Tumor Suppressor Protein p53
business
Zdroj: PLoS ONE
PLoS ONE, Vol 15, Iss 9, p e0232807 (2020)
ISSN: 1932-6203
Popis: Here we have improved an existing mouse model of prostate cancer based on prostate-specific deletion of Pten and Trp53 by incorporating a Cre-activatable luciferase reporter. By coupling the deletion of those genes to the activation of a luciferase reporter, we were able to monitor tumor burden non-invasively over time. We show that, consistent with previous reports, deletion of both Pten and Trp53 on a C57BL/6 background accelerates tumor growth and results in both the loss of androgen receptor expression and castrate resistant tumors as compared with loss of Pten alone. Loss of Trp53 results in the development of sarcomatoid histology and the expression of markers of epithelial-to-mesenchymal transition Zeb1 and vimentin, with kinetics and penetrance dependent on whether one or both alleles of Trp53 were deleted. Homozygous deletion of Trp53 and Pten resulted in uniformly lethal disease by 25 weeks. While we were able to detect locally invasive disease in the peritoneal cavity in aggressive tumors from the double knockout mice, we were unable to detect lymphatic or hematogenous metastatic disease in lymph nodes or at distant sites.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje